Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared Atherosclerosis‘s post on LinkedIn, adding:
“A fantastic read worthy of a download – authors conclusion: ‘The future of atherothrombosis management lies in early detection, integrated targeting of multiple pathogenic pathways, and individualized patient care.'”
Atherosclerosis shared a post on LinkedIn about a recent article by L. Badimon et. al, adding:
“Could atherosclerosis become a chronic, controlled disease rather than a rupture-prone condition?
Intensive lipid lowering does more than reduce cardiovascular risk.
It can change plaque composition, promote stabilization, and in some cases induce regression.
At the same time, emerging anti-inflammatory therapies are beginning to address the residual risk that persists even after LDL cholesterol has been lowered.
The challenge now is identifying the right biological target for the right patient.
Could targeting lipids and inflammation together redefine the natural history of atherothrombosis?
Curious to explore how new therapies are reshaping the biology of atherosclerotic plaques?”
Title: A new era in atherothrombosis
Authors: L. Badimona, G. Vilahurb, G. Mendieta
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 12:14Garima Sharma: Community Clinical Linkages for Better Postpartum Cardiovascular Care
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?